$JBIO
Jade Biosciences, Inc. Common Stock
XNAS
Why is JBIO up today? It is at $22.08 (+1.75%), and our scanner flagged it 36 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JBIO spikes, and full due diligence on JBIO — key stats, earnings, dilution and insider activity. Free.
Get free $JBIO alerts the moment volume spikes
Our scanner flagged $JBIO 36 times in the last 30 days. Create a free account to track $JBIO, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $22.08
- Change today
- +1.75%
- Previous close
- $21.70
- 52-week range
- $6.67 – $28.00
- Market cap
- $1.07B
- Institutional own.
- 87.17%
- Total held
- 100.0%
- Short interest
- 7.5M ▼ -8% vs prior · as of 2026-07-15
- Days to cover
- 7.2d
- Avg daily volume
- 508K
- Next earnings
- Aug 12 · in 6d
- Exchange
- XNAS
- 5m
- 0.5x
- 15m
- 0.4x
- 1h
- 1.2x
- 1D
- 0.3x
Get free JBIO + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $JBIO up today?
JBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on JBIO today, peaking at 2.0x its normal volume.
Likely catalystClinical / FDA update, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
1 open-market buy0 buys, 0 sells last 3 months (5/0 over 12 months)Show 7 recent transactionsMinimize 7 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Frohlich Tom Officer | Acquired (grant/award) | +79K 0.2% of company | added 100% | 86K | n/a | Feb 12, 26 |
King Andrew James Officer | Acquired (grant/award) | +41K 0.08% of company | added 12% | 386K | n/a | Feb 12, 26 |
Balta Elizabeth Officer | Acquired (grant/award) | +28K 0.06% of company | n/a | 28K | n/a | Feb 12, 26 |
Dahms Bradford D. Officer | Acquired (grant/award) | +38K 0.08% of company | n/a | 38K | n/a | Feb 12, 26 |
Fairmount Funds Management Llc Director | Acquired (grant/award) | +1.33M 2.7% of company | added 41% | 4.55M | $12.2M at $9.14 | Oct 6, 25 |
Frohlich Tom Officer | Bought (open market) | +6K 0.01% of company | n/a | 6K | $44K at $7.40 | May 16, 25 |
Ra Capital Management, L.P. Beneficial Owner (10%) | Acquired (grant/award) | +1.06M 2.2% of company | added 100% | 1.32M | n/a | Apr 28, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $JBIO runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $15.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$JBIO Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$JBIO Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
JBIO stock FAQ
Why is $JBIO up today?
JBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on JBIO today, peaking at 2.0x its normal volume.
What is the JBIO stock price today?
JBIO last traded at $22.08, up 1.75% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does JBIO report earnings?
Jade Biosciences, Inc. Common Stock (JBIO) is next expected to report earnings on Wednesday, August 12, 2026, about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live JBIO alerts?
The JBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JBIO 36 times in the last 30 days.
What exchange is JBIO on?
JBIO (Jade Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.07B.
Is JBIO good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.